Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: A Novel candidate for food-drug interaction

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 5, 2011, Pages 486-493

  Uwai, Yuichi ^a   Ozeki, Yukihiro ^a   Isaka, Tomonori ^a   Honjo, Hiroaki ^a   Iwamoto, Kikuo ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Caffeic acid; Food drug interaction; hOAT1; hOAT3; Transport

Indexed keywords

4 AMINOHIPPURIC ACID; ANTIVIRUS AGENT; CAFFEIC ACID; CHLOROGENIC ACID; ESTRONE SULFATE; FOLIC ACID ANTAGONIST; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; QUINIC ACID;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; FEMALE; FOOD DRUG INTERACTION; IC 50; KIDNEY TUBULE ABSORPTION; NONHUMAN; OOCYTE TRANSPORT; XENOPUS LAEVIS;

EID: 80055099306     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-RG-020     Document Type: Article

References (29)

1. El-Sheikh, A. A., Masereeuw, R. and Russel, F. G.: Mechanisms of renal anionic drug transport. Eur. J. Pharmacol., 585: 245-255 (2008).
2. Shitara, Y., Sato, H. and Sugiyama, Y.: Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu. Rev. Pharmacol. Toxicol., 45: 689-723 (2005).
3. Ueo, H., Motohashi, H., Katsura, T. and Inui, K.: Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem. Pharmacol., 70: 1104-1113 (2005).
4. Thyss, A., Milano, G., Kubar, J., Namer, M. and Schneider, M.: Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet, 327: 256-258 (1986).
5. Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Hosoyamada, M., Cha, S. H., Sekine, T. and Endou, H.: Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J. Pharmacol. Exp. Ther., 302: 666-671 (2002).
6. Uwai, Y., Taniguchi, R., Motohashi, H., Saito, H., Okuda, M. and Inui, K.: Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3. Drug Metab. Pharmacokinet., 19: 369-374 (2004).
7. Nozaki, Y., Kusuhara, H., Kondo, T., Iwaki, M., Shiroyanagi, Y., Nakayama, H., Horita, S., Nakazawa, H., Okano, T. and Sugiyama, Y.: Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J. Pharmacol. Exp. Ther., 322: 1162-1170 (2007).
8. Ho, E. S., Lin, D. C., Mendel, D. B. and Cihlar, T.: Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol., 11: 383-393 (2000).
9. Bailey, D. G., Spence, J. D., Munoz, C. and Arnold, J. M.: Interaction of citrus juices with felodipine and nifedipine. Lancet, 337: 268-269 (1991).
10. Harris, R. Z., Jang, G. R. and Tsunoda, S.: Dietary effects on drug metabolism and transport. Clin. Pharmacokinet., 42: 1071-1088 (2003).
11. Bailey, D. G.: Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br. J. Clin. Pharmacol., 70: 645-655 (2010).
12. Whitley, A. C., Sweet, D. H. and Walle, T.: The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metab. Dispos., 33: 1097-1100 (2005).
13. Hong, S. S., Seo, K., Lim, S. C. and Han, H. K.: Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol. Res., 56: 468-473 (2007).
14. Clifford, M. N.: Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J. Sci. Food Agric., 79: 362-372 (1999).
15. Higdon, J. V. and Frei, B.: Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr., 46: 101-123 (2006).
16. Chen, Z.-Y., Peng, C., Jiao, R., Wong, Y. M., Yang, N. and Huang, Y.: Anti-hypertensive nutraceuticals and functional foods. J. Agric. Food Chem., 57: 4485-4499 (2009).
17. Olthof, M. R., Hollman, P. C. and Katan, M. B.: Chlorogenic acid and caffeic acid are absorbed in humans. J. Nutr., 131: 66-71 (2001).
18. Chung, T.-W., Moon, S.-K., Chang, Y.-C., Ko, J.-H., Lee, Y.-C., Cho, G., Kim, S.-H., Kim, J.-G. and Kim, C.-H.: Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J., 18: 1670-1681 (2004).
19. Jung, U. J., Lee, M.-K., Park, Y. B., Jeon, S.-M. and Choi, M.-S.: Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J. Pharmacol. Exp. Ther., 318: 476-83 (2006).
20. Chao, C.-Y., Mong, M.-C., Chan, K.-C. and Yin, M.-C.: Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol. Nutr. Food Res., 54: 388-395 (2010).
21. Uwai, Y. and Iwamoto, K.: Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: comparison with methotrexate. Drug Metab. Pharmacokinet., 25: 163-169 (2010).
22. Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Yee, S. W., Zamek-Gliszczynski M. J. and Zhang, L. for The International Transporter Consortium: Membrane transporters in drug development. Nat. Rev. Drug Discov., 9: 215-236 (2010).
23. Kempf, K., Herder, C., Erlund, I., Kolb, H., Martin, S., Carstensen, M., Koenig, W., Sundvall, J., Bidel, S., Kuha, S. and Tuomilehto, J.: Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am. J. Clin. Nutr., 91: 950-957 (2010).
24. Kurlbaum, M. and Högger, P.: Plasma protein binding of polyphenols from maritime pine bark extract (USP). J. Pharm. Biomed. Anal., 54: 127-132 (2011).
25. Renouf, M., Marmet, C., Guy, P., Fraering, A.-L., Longet, K., Moulin, J., Enslen, M., Barron, D., Cavin, C., Dionisi, F., Rezzi, S., Kochhar, S., Steiling, H. and Williamson, G.: Nondairy creamer, but not milk, delays the appearance of coffee phenolic acid equivalents in human plasma. J. Nutr., 140: 259-263 (2010).
26. Mulato, A. S., Ho, E. S. and Cihlar, T.: Nonsteroidal antiinflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J. Pharmacol. Exp. Ther., 295: 10-15 (2000).
27. Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Kobayashi, Y., Yamamoto, T., Cha, S. H., Sekine, T. and Endou, H.: Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J. Pharmacol. Exp. Ther., 300: 918-924 (2002).
28. Uwai, Y., Ida, H., Tsuji, Y., Katsura, T. and Inui, K.: Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharm. Res., 24: 811-815 (2007).
29. Gill, K. S. and Wood, M. J.: The clinical pharmacokinetics of famciclovir. Clin. Pharmacokinet., 31: 1-8 (1996).